$82.64−$1.18 (-1.41%)as of market close, Jul 24, 2026
EW — Edwards Lifesciences Corporation stock price, chart and key statistics
Key stats
Price data
- Price
- $82.64
- Change YTD
- -3.15%
- Market cap
- 47.6B
- Enterprise value
- 45.7B
- Shares outstanding
- 575.8M
- 52W low
- $72.30
- 52W high
- $96.29
- From 52W high
- -14.18%
- From 52W low
- +14.30%
- 52W range
- 43%
- Beta
- 0.85
Volume
- Rel volume
- 3.07×
- 30D volume
- 5.2M
- 30D $ vol
- 461M
Fundamentals
- Sales (ttm)
- 6.3B
- Sales/share
- $10.95
- EPS (ttm)
- $1.89
- FCF (ttm)
- 1.1B
- FCF/share
- $1.89
- Book value/share
- $17.94
- Net margin
- 17.39%
- ROE
- 10.61%
- ROA
- 8.23%
- Debt / equity
- 0.06×
- Current ratio
- 4.42
Growth (CAGR, ttm) · 10Y
- Sales
- +9.26%
- Net income
- n/a
- FCF
- +8.68%
- Shares
- -0.98%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +9.20%
- Sales/share
- +10.34%
- FCF/share
- +9.76%
- Book value/share
- +17.36%
- Price
- +8.84%
- Total return
- +8.84%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 43.4×
- Fwd P/E
- 25.1×
- P/S (ttm)
- 7.5×
- P/B (mrq)
- 4.6×
- P/FCF (ttm)
- 43.7×
- EV/EBITDA (fy)
- 32.2×
- EV/Sales (ttm)
- 7.3×
- FCF yield (ttm)
- 2.29%
- Buyback yield (ttm)
- 2.22%
- Shareholder yield (ttm)
- 2.22%
Vs own 10Y history
- P/E
- 38th
- P/S
- 14th
- P/B
- 12th
- P/FCF
- 28th
Bar = where today's multiple sits in EW's own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance
1D
-1.41%
1W
-3.60%
1M
-7.83%
3M
+3.66%
YTD
-3.15%
1Y
+7.45%
5Y
-22.71%
Financial statements
Open full EW financials →Related Healthcare
1MEdwards Lifesciences Corporation (EW) trades at $82.64 with a live price and an interactive chart covering 26+ years of daily price history, plus key valuation metrics. ChartRow also publishes EW's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full EW financial statements →